Literature DB >> 11146467

Unusual renal features of Lowe syndrome in a mildly affected boy.

A Gropman1, S Levin, L Yao, T Lin, S Suchy, S Sabnis, D Hadley, R Nussbaum.   

Abstract

The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by congenital cataracts, mental retardation, and renal tubular dysfunction. The gene responsible for OCRL was identified by positional cloning and encodes a lipid phosphatase, phosphatidylinositol 4,5, bisphosphate [PtdIns(4,5)P2]5-phosphatase, which localizes to the Golgi apparatus and is suspected to play a role in Golgi vesicular transport [Suchy et al., 1995]. In addition to the ocular and renal manifestations, most boys with OCRL have cognitive problems and maladaptive behaviors including tantrums and stereotypies. We report a boy with a history of congenital cataracts and mild developmental delay who was also found to have hematuria with proteinuria but minimal signs of renal tubular dysfunction. Subsequent renal biopsy was compatible with a diagnosis of a noncomplement fixating chronic glomerulonephritis. Despite the atypical renal findings, skin fibroblast analysis for PtdIns (4,5)P2 5-phosphatase was performed, and enzyme activity was low, consistent with the diagnosis of OCRL. Western blot analysis from cell lysates showed the ocrl protein was decreased in size and amount. Our report shows atypical renal features of OCRL in a mildly affected boy. The possibility of OCRL should be considered in boys with cataracts and glomerular disease, even in the absence of renal tubular defects and frank mental retardation usually associated with the syndrome. Am. J. Med. Genet. 95:461-466, 2000. Published Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146467     DOI: 10.1002/1096-8628(20001218)95:5<461::aid-ajmg10>3.0.co;2-d

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Defect in phosphoinositide signalling through a homozygous variant in PLCB3 causes a new form of spondylometaphyseal dysplasia with corneal dystrophy.

Authors:  Salma Ben-Salem; Sarah M Robbins; Nara Lm Sobreira; Angeline Lyon; Aisha M Al-Shamsi; Barira K Islam; Nadia A Akawi; Anne John; Pramathan Thachillath; Sania Al Hamed; David Valle; Bassam R Ali; Lihadh Al-Gazali
Journal:  J Med Genet       Date:  2017-11-09       Impact factor: 6.318

2.  OCRL1 mutation in a boy with Dent disease, mild mental retardation, but without cataracts.

Authors:  Vladimir J Lozanovski; N Ristoska-Bojkovska; P Korneti; Z Gucev; V Tasic
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

3.  The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization.

Authors:  Sharon F Suchy; Robert L Nussbaum
Journal:  Am J Hum Genet       Date:  2002-11-11       Impact factor: 11.025

4.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

5.  [Clinical and genetic results with reference to corneal alterations in Lowe-syndrome].

Authors:  G Rudolph; P Kalpadakis; W Röschinger; C Haritoglou; S Kammerer; K-P Boergen; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

6.  Importance of patient selection criteria in determining diagnostic copy number variations in patients with multiple congenital anomaly/mental retardation.

Authors:  Şule Altıner; Nüket Yürür Kutlay
Journal:  Mol Cytogenet       Date:  2019-05-27       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.